Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX11 in Type 2 Diabetes Mellitus
NCT07340320Phase 2Recruiting
- Sponsor
- CORXEL Pharmaceuticals
- Start
- Feb 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of VCT220 in type 2 diabetes mellitus (T2DM), sponsored by CORXEL Pharmaceuticals. Started Feb 2026; status: recruiting.
02
Drugs
VCT220
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07340320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340320.